Compare BC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BC | INSP |
|---|---|---|
| Founded | 1845 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | BC | INSP |
|---|---|---|
| Price | $69.75 | $138.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 15 |
| Target Price | $67.92 | ★ $127.07 |
| AVG Volume (30 Days) | 831.0K | ★ 1.5M |
| Earning Date | 10-23-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | N/A | ★ 1.48 |
| Revenue | ★ $5,183,900,000.00 | $882,622,000.00 |
| Revenue This Year | $2.88 | $14.97 |
| Revenue Next Year | $5.48 | $11.81 |
| P/E Ratio | ★ N/A | $92.68 |
| Revenue Growth | N/A | ★ 16.81 |
| 52 Week Low | $41.00 | $70.77 |
| 52 Week High | $79.84 | $216.01 |
| Indicator | BC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 76.95 |
| Support Level | $65.01 | $132.39 |
| Resistance Level | $68.30 | $142.56 |
| Average True Range (ATR) | 2.35 | 7.26 |
| MACD | 0.71 | 3.75 |
| Stochastic Oscillator | 87.40 | 90.18 |
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 440 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.